Top compounds associated with response to NDUFB1


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC -0.085 0.2
mRNA alisertib CTRPv2 pan-cancer AAC -0.045 0.2
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.043 0.2
mRNA 5-FU CTRPv2 pan-cancer AAC -0.049 0.2
mRNA BIRB 0796 GDSC1000 pan-cancer AAC -0.051 0.2
mRNA Panobinostat CCLE pan-cancer AAC 0.06 0.2
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.051 0.2
mRNA SB52334 GDSC1000 pan-cancer AAC 0.048 0.2
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
Download CSV